Psychiatric comorbidity in childhood onset immune-mediated diseases: A systematic review and meta-analysis
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Standard
Psychiatric comorbidity in childhood onset immune-mediated diseases : A systematic review and meta-analysis. / Jansson, Sabine; Malham, Mikkel; Wewer, Vibeke; Rask, Charlotte Ulrikka.
I: Acta Paediatrica, International Journal of Paediatrics, Bind 111, Nr. 3, 2022, s. 490-499.Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Psychiatric comorbidity in childhood onset immune-mediated diseases
T2 - A systematic review and meta-analysis
AU - Jansson, Sabine
AU - Malham, Mikkel
AU - Wewer, Vibeke
AU - Rask, Charlotte Ulrikka
N1 - Funding Information: S. Jansson was supported with a research year scholarship from the Lundbeck Foundation Publisher Copyright: © 2022 Foundation Acta Pædiatrica. Published by John Wiley & Sons Ltd.
PY - 2022
Y1 - 2022
N2 - Aim: To estimate psychiatric comorbidity in childhood onset immune-mediated inflammatory diseases (IMID).MethodsThe PRISMA guidelines were followed, and the protocol was registered at Prospero (ID: CRD42021233890). Literature was searched in PubMed, PsycINFO and Embase. Original papers on prevalence rates of diagnosed psychiatric disorders and/or suicide in paediatric onset inflammatory bowel disease (pIBD), rheumatic diseases (RD) and autoimmune liver diseases were selected. Pooled prevalence rates of psychiatric disorders (grouped according to ICD-10 criteria) within the various IMID were calculated using random-effects meta-analysis. Risk of bias was evaluated by the Newcastle-Ottawa scale.ResultsTwenty-three studies were included; 13 describing psychiatric disorders in pIBD and 10 in RD. Anxiety and mood disorders were mostly investigated with pooled prevalence rates in pIBD of 6% (95% confidence interval (CI): 4%–9%) and 4% (95%CI: 2%–8%), respectively, in register-based studies, and 33% (95%CI: 25%–41%) and 18% (95%CI: 12%–26%), respectively, in studies using psychiatric assessment. In RD, rates were 13% (95%CI: 12%–15%) for anxiety disorders and 20% (95%CI: 15%–26%) for mood disorders based on psychiatric assessment.ConclusionAnxiety and depression are commonly reported in childhood onset IMID. Physicians should be attentive to mental health problems in these patients as they seem overlooked.
AB - Aim: To estimate psychiatric comorbidity in childhood onset immune-mediated inflammatory diseases (IMID).MethodsThe PRISMA guidelines were followed, and the protocol was registered at Prospero (ID: CRD42021233890). Literature was searched in PubMed, PsycINFO and Embase. Original papers on prevalence rates of diagnosed psychiatric disorders and/or suicide in paediatric onset inflammatory bowel disease (pIBD), rheumatic diseases (RD) and autoimmune liver diseases were selected. Pooled prevalence rates of psychiatric disorders (grouped according to ICD-10 criteria) within the various IMID were calculated using random-effects meta-analysis. Risk of bias was evaluated by the Newcastle-Ottawa scale.ResultsTwenty-three studies were included; 13 describing psychiatric disorders in pIBD and 10 in RD. Anxiety and mood disorders were mostly investigated with pooled prevalence rates in pIBD of 6% (95% confidence interval (CI): 4%–9%) and 4% (95%CI: 2%–8%), respectively, in register-based studies, and 33% (95%CI: 25%–41%) and 18% (95%CI: 12%–26%), respectively, in studies using psychiatric assessment. In RD, rates were 13% (95%CI: 12%–15%) for anxiety disorders and 20% (95%CI: 15%–26%) for mood disorders based on psychiatric assessment.ConclusionAnxiety and depression are commonly reported in childhood onset IMID. Physicians should be attentive to mental health problems in these patients as they seem overlooked.
KW - autoimmune liver disease
KW - inflammatory bowel disease
KW - mental health
KW - rheumatic disease
KW - suicide
U2 - 10.1111/apa.16246
DO - 10.1111/apa.16246
M3 - Review
C2 - 34986519
AN - SCOPUS:85123891000
VL - 111
SP - 490
EP - 499
JO - Acta Paediatrica
JF - Acta Paediatrica
SN - 0803-5253
IS - 3
ER -
ID: 309276881